# The COMPASSION Study

> **NCT06507930** · NA · RECRUITING · sponsor: **Dana-Farber Cancer Institute** · enrollment: 200 (estimated)

## Conditions studied

- Breast Cancer
- Metastatic Breast Cancer
- Advanced Breast Cancer
- Unresectable Breast Carcinoma

## Interventions

- **OTHER:** Telehealth Hospice Visits

## Key facts

- **NCT ID:** NCT06507930
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-01
- **Primary completion:** 2026-10-01
- **Final completion:** 2027-03-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06507930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06507930, "The COMPASSION Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06507930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*